Loading...
Loading...
Among the 7 tracked institutional investors we monitor, DMAC (DIAMEDICA THERAPEUTICS INC) is held with a combined value of $30.62M across 4,396,220 shares. The largest holder is BlackRock, Inc. with a position worth $12.57M (0.00% of their portfolio). 2 funds opened new positions in the most recent quarter. 4 funds increased their holdings. 1 fund reduced its position.
Total Institutional Value
$30.62M
Total Shares Held
4,396,220
Institutional Holders
7
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | $12.57M | 0.00% | -2.4% |
| 2 | MILLENNIUM MANAGEMENT LLC | $6.33M | 0.00% | +21.7% |
| 3 | VANGUARD GROUP INC | $5.76M | 0.00% | New |
| 4 | STATE STREET CORP | $4.36M | 0.00% | +2.6% |
| 5 | CITADEL ADVISORS LLC | $1.18M | 0.00% | +15.1% |
| 6 | RENAISSANCE TECHNOLOGIES LLC | $355.58K | 0.00% | New |
| 7 | FMR LLC | $70.83K | 0.00% | +480.0% |
As of the latest SEC 13F filings, BlackRock, Inc. is the largest institutional holder of DMAC with a position worth $12.57M, representing 0.00% of their portfolio. In total, 7 institutional investors hold DMAC with a combined value of $30.62M.
In the most recent quarter, 2 funds opened a new position in DMAC. Additionally, 4 increased their holdings and 1 reduced their positions.
Institutional investors hold $30.62M worth of DMAC stock across 7 positions. The largest institutional holder is BlackRock, Inc. with $12.57M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For DMAC, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their DMAC positions.